
Brad Lander
@bradlander18
Cardiologist | Director, Sports Cardiology @UHhospitals @HarringtonHVI | Hypertrophic Cardiomyopathy and Echo. Views My Own.
ID: 48884037
20-06-2009 01:00:36
209 Tweet
509 Followers
807 Following

Honored to co-author this piece with so many people I look up to in sports cardiology! ‘Advocacy in Sports Cardiology: A Call to Arms - ScienceDirect’ JACC Journals ACC Advocacy sciencedirect.com/science/articl…



+1. Exciting news from #HRS2024! Today, Dr. Eugene H Chung, Director of Sports E.P. MassGeneral News , alongside Dr. Rachel Lampert (Yale), unveiled the new HRS guidance on arrhythmia management in athletes. Take a look 👉🏾 bit.ly/4dM6Pzq #SportsCardiology #HRS2024



Fantastic kick off event for our Young Adult Oncology Education Series University Hospitals Case Comp Cancer Ctr discussing early onset GI cancers and hereditary cancer syndromes Emily Steinhagen Mike Daunov ChesleyC Lauren Henke, MD, MSCI Madison Conces, MD Rohan Patel, MD, MPH KateDaunov



Timely publication of our editorial Jase Wilson American Society of Echocardiography re: the controversy over LV trabeculations in elite athletes as our session at #ASE2024 tomorrow discusses multimodality imaging in athletes w/ Matthew W Martinez Dermot Phelan Vera Rigolin UH Harrington Heart & Vascular Institute onlinejase.com/article/S0894-…





Apply for the 7/2025 HCM/Sports Cardiology fellowship! Unique experience with high Patient & imaging volume, interventional/surgical expertise. Looking forward to expanding the field of experts. Robyn Bryde, MD Brad Lander Hypertrophic Cardiomyopathy Medical Society ahs.atlantichealth.org/professionals-…


Takeaways from the 2024 HCM Guidelines and Differences between the US and Europe Guidelines by Dr. Carolyn Ho Hypertrophic Cardiomyopathy Medical Society sessions today. Approach to competitive exercise is different than in 2020 and between US and Europe Matthew W Martinez


Captivating talk by Anjali Owens today Hypertrophic Cardiomyopathy Medical Society meeting about gaps in the 2024 HCM guidelines including: personalizing thickness measurements for dx, new causative genes, medical rx of mid cavity obstruction, SGLT2i/GLP1 use, cardiac myosin inhibitors in asymptomatic HCM & more


Thoughtful (and humorous) talk by Michael Parker Ayers, MD, FACC about an approach to patients with obstructive HCM who don't improve with cardiac myosin inhibitors at Hypertrophic Cardiomyopathy Medical Society today



Thank you Ohio Chapter-ACC for the invitation. Great lineup of other interesting podcasts as well.